Belgian politicians raise concerns on pharma regulatory data protection change [Advocacy Lab Content]

In its last stretch, the Belgian Presidency of the Council of the EU is discussing regulatory data protection (RDP) for medicinal products. The goal is to balance pharmaceutical innovation with timely patient access across the EU.